Take action in addressing health inequities in your community.
Featured stories and the latest news on what it takes to advance science for life
Xtra Deliverability. Optimal Healing.
Medical Specialties > Interventional Cardiology > Coronary Interventions > PCI Product Portfolio > SYNERGY XD™ Bioabsorbable Polymer Stent
The SYNERGY XD Stent can be safely used in conjunction with shortened DAPT in patients at high risk for bleeding, based on the results from the EVOLVE Short DAPT Trial.*
Studying 3-month DAPT in high bleeding risk patients†1
from 3-15 months
Unlike permanent polymer DES technology, the SYNERGY XD Bioabsorbable Polymer is gone shortly after the drug is completely eluted2
Studying 1-month DAPT in elderly patients‡§3
from 1-12 months**
Studying 0-month DAPT in patients with chronic stable angina‡††4
SYNERGY BP Stent ranked #1 for the lowest relative risk of def/prob ST at 1-year. §5
Lowest relative risk of Def/Prob ST
Lowest ST rate compared to newer generation DES despite use in patients with statistically more Class B2/C lesions, diabetes, prior PCI, and 3VD.*,**,6
Excellent Results in
Lowest ST rate in statistically more complex patients